• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ProShares Ultra Nasdaq Biotechnology (NQ:BIB)

79.64 -0.14 (-0.18%)
Official Closing Price Updated: 4:15 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,072
Open 80.00
Bid (Size) 77.39 (100)
Ask (Size) 81.57 (100)
Prev. Close 79.78
Today's Range 78.80 - 80.41
52wk Range 33.77 - 84.34
Shares Outstanding N/A
Dividend Yield 0.91%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
How Abivax Went From Biotech Nobody To M&A Bullseye After A Single Blockbuster Readout This Year ↗
December 24, 2025
A 1,900% rally, Phase 3 wins, and takeover chatter around Eli Lilly have transformed Abivax from a risky clinical bet into a strategic asset with real optionality. 
Via Stocktwits
News headline image
Artiva Biotherapeutics Gets A Price Target Hike From Wedbush: Stock Rallies 99% But Retail Expects Further Rally ↗
October 17, 2025
Wedbush’s new price target implies a whopping 730% potential upside to the stock’s closing price on Thursday. 
Via Stocktwits

Performance

YTD
N/A
N/A
1 Month
-2.7%
-2.7%
3 Month
+24.5%
+24.5%
6 Month
+69.7%
+69.7%
1 Year
+53.5%
+53.5%

More News

Read More
News headline image
Pharma Tariffs Back In Spotlight On New Trump Threat ↗
September 26, 2025
Via Investor's Business Daily
Topics ETFs Government World Trade
News headline image
Donald Trump Is Finally Making Good On Pharma Tariffs Threats, But Stocks Yawn ↗
July 16, 2025
Via Investor's Business Daily
Topics ETFs Government World Trade
News headline image
Friday Trades And June Summary ↗
July 03, 2021
Via Talk Markets
News headline image
Trump Threatens To Slam Pharmaceuticals With Up To 200% Tariffs ↗
July 08, 2025
Via Investor's Business Daily
Topics ETFs Economy Government
News headline image
Lifeline For 23andMe? Stock Jumps After Court Greenlights Bankruptcy Asset Sale, Retail Weighs Possible Rescue Deals ↗
March 28, 2025
Via Stocktwits
Topics Bankruptcy
News headline image
Tonix Pharma Dominates Retail Biotech Buzz After 1-for-100 Reverse Split, Sentiment Turns Neutral Amid Volatility ↗
February 05, 2025
Via Stocktwits
News headline image
Small-Cap NRx Pharma’s Stock Draws Heavy Retail Buzz After Securing $27M Funding ↗
January 29, 2025
Via Stocktwits
News headline image
Amgen, Inc. Dividend Stock Analysis ↗
July 05, 2024
Via Talk Markets
News headline image
Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich ↗
March 25, 2024
Via InvestorPlace
News headline image
The 7 Best ETFs to Buy to Cover 2023’s Biggest Investing Opportunities ↗
December 20, 2022
Via InvestorPlace
News headline image
The 7 Hottest Biotech Stocks to Own in 2023 and Beyond ↗
December 18, 2022
Via InvestorPlace
News headline image
Market Briefing For Tuesday, July 5, 2022 ↗
July 04, 2022
Via Talk Markets
News headline image
Psychedelics Company COMPASS Pathways To Join NASDAQ Biotechnology Index ↗
December 17, 2021
Via Benzinga
News headline image
Take A Look At The Top-Performing Biotech ETFs YTD ↗
October 02, 2021
Via Talk Markets

Frequently Asked Questions

Is ProShares Ultra Nasdaq Biotechnology publicly traded?
Yes, ProShares Ultra Nasdaq Biotechnology is publicly traded.
What exchange does ProShares Ultra Nasdaq Biotechnology trade on?
ProShares Ultra Nasdaq Biotechnology trades on the Nasdaq Stock Market
What is the ticker symbol for ProShares Ultra Nasdaq Biotechnology?
The ticker symbol for ProShares Ultra Nasdaq Biotechnology is BIB on the Nasdaq Stock Market
What is the current price of ProShares Ultra Nasdaq Biotechnology?
The current price of ProShares Ultra Nasdaq Biotechnology is 79.64
When was ProShares Ultra Nasdaq Biotechnology last traded?
The last trade of ProShares Ultra Nasdaq Biotechnology was at 01/02/26 04:15 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap